Market Overview:

The global gastrointestinal stents market size reached US$ 409.0 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 508.6 Million by 2028, exhibiting a growth rate (CAGR) of 3.5% during 2023-2028.

 A gastrointestinal stent refers to an artificial tube graft that is inserted in the body to prevent blockages in the gullet, stomach and small intestine. It is an expandable metal or a plastic mesh tube that is placed in an anatomical duct, such as bile ducts, esophagus, bowel or colon, and blockages due to cancerous tissues. It aims to remove the obstruction and reduce the pressure caused by inflammation. Some of the most common types of gastrointestinal stents include biliary, colonic, duodenal, esophageal and pancreatic stents.

The rising prevalence of colorectal cancer across the globe is one of the key factors driving the growth of the market. Furthermore, an increasing geriatric population suffering from gastrointestinal diseases, such as bowel ailments, diverticulosis and gastrointestinal malignancies, is also providing a boost to the market growth. Additionally, the growing preference for minimally invasive (MI) surgical procedures, along with the rising health consciousness among the masses, is creating a significant impact on the market. In comparison to the traditional open surgery procedures, gastrointestinal stenting involves low risk of infections, minimal loss of blood and quick recuperation period. Moreover, various technological advancements, including the development of bio-absorbable and nitinol material-based stents offering a high degree of flexibility and kink-resistance, is acting as another growth-inducing factor. Other factors, including significant growth in the healthcare infrastructure, the implementation of favourable government policies and extensive research and development (R&D) activities, are projected to drive the market further. 

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global gastrointestinal stents market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product type, technology type, material and end user.

Breakup by Product Type:

• Biliary Stents
• Duodenal Stents
• Colonic Stents
• Pancreatic Stents
• Esophageal Stents
   

Breakup by Technology Type:

• Anti-Migratory Stents
• Drug-Eluting Stents
• Radioactive Stents
• Anti-Reflux Stents
• Shape-Modified Stents
• Others
   

Breakup by Material:

• Plastic Stents
• Self-Expanding Metal Stents
  • Stainless Steel Stents
  • Nitinol Stents
  • Others
• Covered Self-Expandable Metallic Stents
• Biodegradable or Drug Eluting Stents
   

Breakup by End User:

• Hospitals
• Specialty Clinics
• Ambulatory Surgical Centres
• Others
   

Breakup by Region:

• North America
  • United States
  • Canada
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
• Latin America
  • Brazil
  • Mexico
  • Others
• Middle East and Africa
   

Competitive Landscape:

The competitive landscape of the industry has also been examined with some of the key players being Becton, Dickinson and Company, Boston Scientific Corporation, Cantel Medical Corporation, Conmed Corporation, Cook Group Incorporated, ELLA-CS, S.R.O., Hobbs Medical Inc., Merit Medical Systems Inc., Olympus Corporation, Taewoong Medical Co. Ltd., etc.

Report Coverage: